Анализ уровня аутоантител при диабетическом кетоацидозе в педиатрической практике

сахарный диабет, диабетический кетоацидоз, аутоантитела, дофаминовые рецепторы, NMDA рецепторы

1. Chiarelli F, Rewers M, Phillip M. Screening of Islet Autoantibodies for Children in the General Population: a Position Statement endorsed by the European Society for Pediatric Endocrinology. Horm Res Paediatr. 2022. https://doi.org/10.1159/000525824. Online ahead of print.

2. Pasi R, Ravi KS. Type 1 diabetes mellitus in pediatric age group: A rising endemic. J Family Med Prim Care. 2022; 11 (1): 27-31. https://doi.org/10.4103/jfmpc.jfmpc_975_21.

3. Raghunathan V, Jevalikar G, Dhaliwal M, Singh D, Sethi SK, Kaur P, Singhi SC. Risk Factors for Cerebral Edema and Acute Kidney Injury in Children with Diabetic Ketoacidosis. Indian J Crit Care Med. 2021; 25 (12): 1446-1451. https://doi.org/10.5005/jp-journals-10071-24038.

4. Baszynska-Wilk M, Wysocka-Mincewicz M, Wajda-Cuszlag M, Swiercz A, Szalecki M. Letter to the Editor: Central Nervous System Complications in Diabetic Ketoacidosis. Pediatr Endocrinol Rev. 2019; 17 (1): 47-49. https://doi.org/10.17458/per.vol17.2019.le.bwwmwc.nervouscomplicationsdiabetic.

5. Gardoni F, Stanic J, Scheggia D, Benussi A, Borroni B, Di Luca M. NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical Features. Cells. 2021; 10 (1): 77. https://doi.org/10.3390/cells10010077.

6. Arinuma Y. Antibodies and the brain: anti-N-methyl-D-aspartate receptor antibody and the clinical effects in patients with systemic lupus erythematosus. Curr Opin Neurol. 2018; 31 (3): 294-299. https://doi.org/10.1097/WCO.0000000000000554.

7. Klein MO, Battagello DS, Cardoso AR, Hauser DN, Bittencourt JC, Correa RG. Dopamine: Functions, Signaling, and Association with Neurological Diseases. Cell Mol Neurobiol. 2019; 39 (1): 31-59. https://doi.org/10.1007/s10571-018-0632-3.

8. Dale RC, Merheb V, Pillai S, Wang D, Cantrill L, Murphy TK, Ben-Pazi H, Varadkar S, Aumann TD, Horne MK, Church AJ, Fath T, Brilot F. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain. 2012; 135 (11): 3453-3468. https://doi.org/10.1093/brain/aws256.

9. Быков ЮВ, Батурин ВА, Углова ТА. Оценка уровней аутоантител к NMDA и дофаминовым рецепторам у детей больных сахарным диабетом I типа в зависимости от тяжести течения заболевания. Медицина. 2020; 8 (2): 73-80. https://doi.org/10.29234/2308-9113-2020-8-2-73-80.